69ɫ��Ƭ

In a Society of Actuaries , 69ɫ��Ƭ's Ryan Holt discusses the confusion matrix and how actuaries have leveraged it in the accelerated underwriting (AU) space.&n... Read More

Asset-intensive reinsurance is growing in popularity in the life insurance industry, and it is more important than ever for insurers to seek out trusted partners when selecting an asset-intensive reinsurer.

Read More

Digital health is here to stay and will continue to grow. Enabling virtual access to healthcare can empower policyholders to actively manage and improve their own health and wellness, while equipping insurers to optimize portfolio management and performance.
Read More

Explore 69ɫ��Ƭctual, our magazine covering innovation, experience, and development for insurance professionals. In this issue, we continue our celebration of 50 years of positive impact. 

Read More

Although much of the spotlight is currently on ChatGPT, the generative artificial intelligence (AI) landscape is much broader. In this article, 69ɫ��Ƭ's Neil Parkin provides an overview of potential opportunities emerging from AI for insurers.

Read More

The Geneva Association recently published a comprehensive report on the ongoing mental health crisis and the insurance industry’s role and responsibility in promoting mental wellbeing to help address this growing societal challenge.

Read More

Learn more about the latest trends and developments in life and health insurance by exploring findings from 69ɫ��Ƭ’s 2022 surveys.  Read More

In this Inside 69ɫ��Ƭ Q&A, Adela Osman, Head of Global Medical, explains why she chose a career in the life and health insurance industry, what 69ɫ��Ƭ Magic means, and how she plans to build on the successful legacy of 69ɫ��Ƭ’s medical team.
Read More

As the need for mental health services and associated insurance coverage increases, the quest for solutions becomes more urgent. Psychedelics may be part of the solution.
Read More

69ɫ��Ƭ provides quarterly updates on global product developments, which can be made available upon request.

Read More

People are talking about ChatGPT, the AI-powered chatbot capable of processing mountains of text data, providing detailed responses to questions, and engaging in conversation like a human. We decided to put ChatGPT to the test and to consider the implications this tool ... Read More

The great promise of gene therapy must be weighed against the challenges of high short-term costs. Effective case management and expanded education efforts will be essential to progress.


Read More

The advent of ultra-sensitive troponin testing has led to changes in the way the test is applied and has led to the discovery of many “troponin positive” illnesses that are not due to coronary artery disease. Read More

Synthetic biotics show significant promise to prevent, diagnose, and treat diseases and improve future mortality and morbidity rates. If these new therapies successfully enter the market in the coming years, they are likely to help transform modern medicine.
Read More

Healthy aging promoted through widespread engagement and inclusion of the elderly could help solve some big problems society and the life and health insurance industry currently face. 
Read More

Growing evidence indicates that introducing behavioral science principles to life insurance documentation can be a critical piece of the highly complex puzzle of solving the protection gap.
Read More

From a disability insurance standpoint and based on numerous articles in the scientific literature and lay press, insurers might have expected a tsunami of long-term COVID disability claims after the expected six-month waiting period. Thus far, however, this has not bee... Read More

69ɫ��Ƭ's Dr. Radi Counsell reviews how modern immunotherapy is transforming cancer outcomes, and the real possibility that it might even cure some highly lethal cancers such as malignant melanoma.
Read More

Reprinted from , this article reviews the latest developments... Read More

In the past few decades, groundbreaking advances have emerged in early diagnosis, treatment, and management of cystic fibrosis (CF), and those with the condition are now living to age 60 and beyond. Why, then, are life insurance companies not yet offering terms to those... Read More